6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
16m ago	JCET Reports 42.7% YoY Surge in Q1 2026 Net Profit Attributable to Shareholders
41m ago	Workday Government Unveils Personnel Action Request (PAR) Agent to Modernize Federal HR and Strengthen Mission Readiness
41m ago	CNOOC Limited Achieves Strong Start with Dual Growth in Production and Performance in Q1 2026
43m ago	onsemi and Geely Expand Strategic Collaboration to Elevate the Driving Experience
43m ago	Myriad Uranium Appoints Eric Miller as Strategic Advisor on US Critical Minerals

About

Nunzia Pharmaceutical Corporation (PINK:NUNZ) — investor relations, events, news, and company updates on 6ix.

Latest News

Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Now Offering a Patented Blood Warmer Through Nunzia's Medical Supply Division. 8K Filed 08/05/2021

Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER

Nunzia Pharmaceutical Corporation, an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Proud to Start Studies on Anxiety-Based Tinnitus

Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals

Cancelling S8 Shares

Financials

Revenue

$0

Market Cap

$43.45 K

EPS

-0.01

Community Chat

Ask AI